title: Comment on: tocilizumab induces corticosteroid sparing in rheumatoid arthritis patients in clinical practice: reply.
authors.affiliation: Department of Rheumatology, Dijon University Hospital, Dijon and INSERM U1093, UFR Médecine, University of Burgundy, France.
authors.forename: Clémentine
authors.initials: C
authors.lastname: Fortunet
authors.affiliation: Department of Rheumatology, Dijon University Hospital, Dijon and INSERM U1093, UFR Médecine, University of Burgundy, France. Department of Rheumatology, Dijon University Hospital, Dijon and INSERM U1093, UFR Médecine, University of Burgundy, France. jean-francis.maillefert@chu-dijon.fr.
authors.forename: Jean Francis
authors.initials: JF
authors.lastname: Maillefert
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011241:Prednisone / Q000627:therapeutic use*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D005938:Glucocorticoids; C502936:tocilizumab; D011241:Prednisone